# FDA WARNING_LETTER - ImprimisRx NJ - August 05, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/imprimisrx-nj/5cc5aba9-596e-4551-9c9b-e341f4d45be9

> FDA WARNING_LETTER for ImprimisRx NJ on August 05, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: ImprimisRx NJ
- Inspection Date: 2022-08-05
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [OTHER_CORRESPONDENCE - 2017-06-19](https://www.globalkeysolutions.net/records/other_correspondence/imprimisrx-nj/cac77b51-1b4c-4dd9-9e34-f7f958d1087e)
- [483_RESPONSE - 2013-08-19](https://www.globalkeysolutions.net/records/483_response/imprimisrx-nj/e42e4f5d-0a10-496c-a641-cf2fe129c440)
- [483 - 2013-08-19](https://www.globalkeysolutions.net/records/483/imprimisrx-nj/60bd6b80-096a-463f-ac9c-fd536416bd2c)
- [483 - 2017-07-10](https://www.globalkeysolutions.net/records/483/imprimisrx-nj/557994ed-7478-4f2c-a5b6-69cb71603297)
- [WARNING_LETTER - 2013-08-19](https://www.globalkeysolutions.net/records/warning_letter/imprimisrx-nj/3685214b-c1b0-4a1b-9edb-0036f1df522d)

## Related Officers

- [Senior Compliance Officer](https://www.globalkeysolutions.net/people/barbara-wilimczyk-macri/36eda42e-09b6-4364-a000-c5cd8ddb70ee)
- [Suja Alum](https://www.globalkeysolutions.net/people/suja-alum/c8815c55-8d66-41e2-8b2e-c805457ae0fb)
- [Program Division Director](https://www.globalkeysolutions.net/people/lisa-m-harlan/e5d04349-6dd6-4f08-b31f-bf719c8413ab)

Company: https://www.globalkeysolutions.net/companies/imprimisrx-nj/4c5c7886-bcf6-4aa1-aa74-882590c33746

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02